2-(1H-1,2,3,4-tetrazol-5-yl)-5-(trifluoromethyl)pyridine, 90%, 100mg

2-(5-Chlorothiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

4-Phenylbutylamine>98.0%(GC)(T)25mL

1-Nitro-3-vinylbenzene, 95.0%, 250mg

(2E)-1-(4-methoxyphenyl)-3-(3-methylphenyl)prop-2-en-1-one, 95.0%, 10g

Wogonin>98.0%(HPLC)50mg

4-Nitro-1H-pyrrolo[2,3-b]pyridine 7-oxide, 95.0%, 250mg

2-[[4-[[4-[Bis-(2-hydroxyethyl)-amino]-phenyl]-(4-chloro-phenyl)-methyl]-phenyl]-(2-hydroxy-ethyl)-amino]-ethanol, 25mg

3-(Bromomethyl)-5-methylpyridine hydrobromide, 95.0%, 10g

Methyl 4-amino-3-methyl-5-nitrobenzoate, 97%, 250mg

3-Bromo-4-chloro-5-fluorobenzonitrile, 95.0%, 1g

(R)-3-Hydroxymethyl-piperidine, 95.0%, 1g

3-Cyclohexylpropan-1-amine, 95.0%, 5g